Robert Lisicki's Net Worth
$2.62 Million
Who is Robert Lisicki?
Robert Lisicki has an estimated net worth of $2.62 Million. This is based on reported shares across multiple companies, which include Zura Bio Ltd, ARENA PHARMACEUTICALS INC, and Cadrenal Therapeutics, Inc..
SEC CIK
Robert Lisicki's CIK is 0001779614
Past Insider Trading and Trends
2021 was Robert Lisicki's most active year for acquiring shares with 6 total transactions. Robert Lisicki's most active month to acquire stocks was the month of December. 2021 was Robert Lisicki's most active year for disposing of shares, totalling 9 transactions. Robert Lisicki's most active month to dispose stocks was the month of February. 2020 saw Robert Lisicki paying a total of $1,228,500.00 for 106,300 shares, this is the most they've acquired in one year. In 2020 Robert Lisicki cashed out on 72,600 shares for a total of $2,315,165.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zura Bio Ltd (ZURA) Snapshot price: $3.62
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARENA PHARMACEUTICALS INC No price found
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -37.56K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +133.30% | 21.46K |
—
|
—
| 37.56K |
Jan 3
| |||
Form 4
|
—
|
0
|
$50.52 | -$334,857.20 | 16.1K |
Scheduled
|
Aug 3
| ||
Form 4
| +70.54% | 6.66K |
—
|
—
| 16.1K |
Mar 1
| |||
Form 4
|
—
|
0
|
$59.91 | -$663,683.39 | 9.44K |
Scheduled
|
Feb 2
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
Form 4
|
∞
| 9.44K |
$77.59 | -$245,106.81 | 9.44K |
Jan 7
| |||
Form 4
| -100.00% | -3.87K |
$66.06 | -$255,785.89 |
0
|
Dec 1
| |||
Form 4
|
∞
| 3.87K |
$65.50 | -$159,034.00 | 3.87K |
Nov 25
| |||
Form 4
|
—
|
0
|
$52.15 | -$671,845.24 |
0
|
Scheduled
|
Aug 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -100.00% | -4.43K |
$45.83 | -$202,999.67 |
0
|
Nov 13
| |||
Form 4
|
∞
| 4.43K |
$47.32 | -$88,535.72 | 4.43K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cadrenal Therapeutics, Inc. (CVKD) Snapshot price: $7.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||